Is Recursion Pharmaceuticals a Millionaire Maker?
Some investors closely monitor the portfolios of billionaires to get ideas. Another approach, however, is to examine the stocks held by highly successful companies.
For example, Nvidia owns stakes in six smaller companies. I think Recursion Pharmaceuticals (NASDAQ: RXRX) is arguably the most intriguing of the group.
Recursion looks like a big dud so far. The biotech stock has plunged roughly 80% since its IPO in 2021. Shares are down around 5% year to date.
Source Fool.com
